Literature DB >> 13664796

Variability in absorption of insulin-I 131 in normal and diabetic subjects after subcutaneous and intramuscular injection.

E W MOORE, M L MITCHELL, T C CHALMERS.   

Abstract

Entities:  

Keywords:  INSULIN/administration

Mesh：

Substances：

Year:  1959        PMID： 13664796      PMCID： PMC293268          DOI： 10.1172/JCI103897

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

1.  Ethanol fractionation of plasma and electrophoretic identification of insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1957-05       Impact factor: 14.808

2.  Physical binding of insulin by gamma globulins of insulin-resistant subjects.

Authors:  B A BURROWS; T PETERS; F C LOWELL
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

3.  Studies with insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  Diabetes       Date:  1957 Sep-Oct       Impact factor: 9.461

4.  The role of nonprecipitating insulin antibodies in diabetes.

Authors:  J H SKOM; D W TALMAGE
Journal:  J Clin Invest       Date:  1958-06       Impact factor: 14.808

5.  Nonprecipitating insulin antibodies.

Authors:  J H SKOM; D W TALMAGE
Journal:  J Clin Invest       Date:  1958-06       Impact factor: 14.808

6.  A comparison of the behavior of insulin and insulin labeled with I 131 in serum.

Authors:  G W SCOTT; T E PROUT; J A WEAVER; S P ASPER
Journal:  Diabetes       Date:  1958 Jan-Feb       Impact factor: 9.461

7.  Insulin I-131 metabolism in man; plasma-binding, distribution and degradation.

Authors:  R W COX; E D HENLEY; G W WELSH; R H WILLIAMS
Journal:  Am J Med       Date:  1956-09       Impact factor: 4.965

8.  The distribution and metabolism of insulin labeled with radioactive iodine (I131) in normal and diabetic subjects.

Authors:  G W WELSH; E D HENLEY; R H WILLIAMS; N J ELGEE
Journal:  Diabetes       Date:  1956 Jan-Feb       Impact factor: 9.461

9.  Studies of insulin binding with isotopically labeled insulin.

Authors:  W C STADIE; N HAUGAARD; M VAUGHAN
Journal:  J Biol Chem       Date:  1952-12       Impact factor: 5.157

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808
View more
  10 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  [New observations on the treatment of chronic insulin resistance and experimental research on its genesis].

Authors:  H DAWEKE; I BACH
Journal:  Klin Wochenschr       Date:  1963-03-15

3.  Modeling absorption kinetics of subcutaneous injected soluble insulin.

Authors:  E Mosekilde; K S Jensen; C Binder; S Pramming; B Thorsteinsson
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

Review 4.  [Chronic insulin resistance].

Authors:  J B Field
Journal:  Acta Diabetol Lat       Date:  1970 Mar-Apr

5.  Pharmacokinetic approach for reconstruction of predetermined plasma insulin profiles by continuous subcutaneous insulin infusion in depancreatized dogs.

Authors:  H Hirayama; Y Kasuya; T Kobayashi; T Itoh; A Yagishita; T Katakura; K Isono
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

6.  Matched glucose responses to insulin administered subcutaneously and intravenously. Evidence for subcutaneous inactivation of insulin.

Authors:  R W Stevenson; T I Tsakok; J A Parsons
Journal:  Diabetologia       Date:  1980-05       Impact factor: 10.122

7.  Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.

Authors:  M Berger; P A Halban; L Girardier; J Seydoux; R E Offord; A E Renold
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

8.  NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.

Authors:  S Jørgensen; A Vaag; L Langkjaer; P Hougaard; J Markussen
Journal:  BMJ       Date:  1989-08-12

Review 9.  The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.

Authors:  P R Gwilt; R R Nahhas; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

10.  Studies on human growth hormone. II. The physiological disposition and metabolic fate of human growth hormone in man.

Authors:  M L PARKER; R D UTIGER; W H DAUGHADAY
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.